Published On: Thu, Sep 10th, 2020

Serum Institute puts India trials of AstraZeneca’s COVID-19 vaccine on hold

Aside from AstraZeneca’s vaccine candidate, there are nine other drugs in phase 3 clinical trials. As of yet, none of them have been halted.

MUMBAI (Reuters) – Serum Institute of India has put trials of AstraZeneca’s COVID-19 vaccine candidate on hold until the British drugmaker restarts the trials, Serum said on Thursday.

“We are reviewing the situation and pausing India trials,” Serum said in a brief statement.

AstraZeneca said on Tuesday it had paused trials of its experimental coronavirus vaccine because of an unexplained illness in a study participant, but its partner Serum had at the time said its trials in India were still ongoing.

Disclaimer :- This story has not been edited by The Sen Times staff and is auto-generated from news agency feeds. Source: Reuters

About the Author

%d bloggers like this: